CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia

被引:219
作者
Tsai, WC [1 ]
Strieter, RM
Mehrad, B
Newstead, MW
Zeng, XY
Standiford, TJ
机构
[1] Univ Michigan, Med Ctr, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/IAI.68.7.4289-4296.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pulmonary infection due to Pseudomonas aeruginosa has emerged as a leading cause of mortality. A vigorous host response is required to effectively clear the organisms from the lungs. This host defense is dependent on the recruitment and activation of neutrophils and macrophages, A family of chemotactic cytokines (chemokines) has been shown to participate in this protective response. In this study, we assessed the role of the ELR+ (glutamic acid-leucine arginine motif positive) CXC chemokines and their CXC chemokine receptor (CXCR2) in lung antibacterial host defense. The intratracheal administration of Pseudomonas to mice resulted in the time-dependent influx of neutrophils to the lung, peaking at 12 to 24 h after inoculation. The influx of neutrophils was associated with a similar time-dependent expression of the ELR+ CXC chemokines, KC, macrophage inflammatory protein 2 (MIP-2), and lipopolysaccharide-induced CXC chemokine (LIX). Selective neutralization of MIP-2 or KC resulted in modest changes in neutrophil influx but no change in bacterial clearance or survival. However, neutralization of CXCR2 resulted in a striking increase in mortality, which was associated with a marked decrease in neutrophil recruitment and bacterial clearance. Conversely, the site-specific transgenic expression of KC resulted in enhanced clearance of bacteria after Pseudomonas challenge. This study indicates that ELR+ CXC chemokines are critical mediators of neutrophil-mediated host defense in Pseudomonas pneumonia.
引用
收藏
页码:4289 / 4296
页数:8
相关论文
共 51 条
[1]  
ANTONY VB, 1993, J IMMUNOL, V151, P7216
[2]  
BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
[3]   The effects of aerosolized dextran in a mouse model of Pseudomonas aeruginosa pulmonary infection [J].
Bryan, R ;
Feldman, M ;
Jawetz, SC ;
Rajan, S ;
DiMango, E ;
Tang, HB ;
Scheffler, L ;
Speert, DP ;
Prince, A .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) :1449-1458
[4]   INACTIVATION OF ANTIBIOTICS AND THE DISSEMINATION OF RESISTANCE GENES [J].
DAVIES, J .
SCIENCE, 1994, 264 (5157) :375-382
[5]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[6]   GENDER DIFFERENCES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA INFECTION [J].
DEMKO, CA ;
BYARD, PJ ;
DAVIS, PB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (08) :1041-1049
[7]   Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells [J].
Denning, GM ;
Wollenweber, LA ;
Railsback, MA ;
Cox, CD ;
Stoll, LL ;
Britigan, BE .
INFECTION AND IMMUNITY, 1998, 66 (12) :5777-5784
[8]   Activation of NF-κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells [J].
DiMango, E ;
Ratner, AJ ;
Bryan, R ;
Tabibi, S ;
Prince, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2598-2605
[9]   INTERLEUKIN-8 AND DEVELOPMENT OF ADULT RESPIRATORY-DISTRESS SYNDROME IN AT-RISK PATIENT GROUPS [J].
DONNELLY, SC ;
STRIETER, RM ;
KUNKEL, SL ;
WALZ, A ;
ROBERTSON, CR ;
CARTER, DC ;
GRANT, IS ;
POLLOK, AJ ;
HASLETT, C .
LANCET, 1993, 341 (8846) :643-647
[10]   By the numbers - US deaths from pneumonia [J].
Doyle, R .
SCIENTIFIC AMERICAN, 1997, 276 (02) :29-29